Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma (Q88985835)
Jump to navigation
Jump to search
scientific article published on 04 June 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma |
scientific article published on 04 June 2018 |
Statements
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma (English)
W Kimryn Rathmell
David F McDermott
Mahrukh A Huseni
Michael B Atkins
Robert J Motzer
Brian I Rini
Bernard Escudier
Lawrence Fong
Richard W Joseph
Sumanta K Pal
James A Reeves
Mario Sznol
John Hainsworth
Walter M Stadler
Thomas Hutson
Martin E Gore
Sergio Bracarda
Cristina Suárez
Riccardo Danielli
Viktor Gruenwald
Dorothee Nickles
Suchit Jhunjhunwala
Elisabeth Piault-Louis
Alpa Thobhani
Jiaheng Qiu
Priti S Hegde
Christina Schiff
Gregg D Fine